Nemati F - Search Results

1

BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers.

Coussy F, El-Botty R, Château-Joubert S, Dahmani A, Montaudon E, Leboucher S, Morisset L, Painsec P, Sourd L, Huguet L, Nemati F, Servely JL, Larcher T, Vacher S, Briaux A, Reyes C, La Rosa P, Lucotte G, Popova T, Foidart P, Sounni NE, Noel A, Decaudin D, Fuhrmann L, Salomon A, Reyal F, Mueller C, Ter Brugge P, Jonkers J, Poupon MF, Stern MH, Bièche I, Pommier Y, Marangoni E. Coussy F, et al. Among authors: nemati f. Sci Transl Med. 2020 Feb 19;12(531):eaax2625. doi: 10.1126/scitranslmed.aax2625. Sci Transl Med. 2020. PMID: 32075943 Free PMC article.

2

Synthesis of self-immolative glucuronide-based prodrugs of a phenol mustard.

Lougerstay-Madec R, Florent JC, Monneret C, Nemati F, Poupon MF. Lougerstay-Madec R, et al. Among authors: nemati f. Anticancer Drug Des. 1998 Dec;13(8):995-1007. Anticancer Drug Des. 1998. PMID: 10335272

3

Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.

Nemati F, Livartowski A, De Cremoux P, Bourgeois Y, Arvelo F, Pouillart P, Poupon MF. Nemati F, et al. Clin Cancer Res. 2000 May;6(5):2075-86. Clin Cancer Res. 2000. PMID: 10815935

4

Distinct experimental efficacy of anti-Fas/APO-1/CD95 receptor antibody in human tumors.

Decaudin D, Beurdeley-Thomas A, Nemati F, Miccoli L, Pouillart P, Bourgeois Y, Gonçalves RB, Rouillard D, Poupon MF. Decaudin D, et al. Among authors: nemati f. Exp Cell Res. 2001 Aug 15;268(2):162-8. doi: 10.1006/excr.2001.5287. Exp Cell Res. 2001. PMID: 11478842

5

Peripheral benzodiazepine receptor ligands reverse apoptosis resistance of cancer cells in vitro and in vivo.

Decaudin D, Castedo M, Nemati F, Beurdeley-Thomas A, De Pinieux G, Caron A, Pouillart P, Wijdenes J, Rouillard D, Kroemer G, Poupon MF. Decaudin D, et al. Among authors: nemati f. Cancer Res. 2002 Mar 1;62(5):1388-93. Cancer Res. 2002. PMID: 11888910

6

In vivo efficacy of STI571 in xenografted human small cell lung cancer alone or combined with chemotherapy.

Decaudin D, de Cremoux P, Sastre X, Judde JG, Nemati F, Tran-Perennou C, Fréneaux P, Livartowski A, Pouillart P, Poupon MF. Decaudin D, et al. Among authors: nemati f. Int J Cancer. 2005 Feb 20;113(5):849-56. doi: 10.1002/ijc.20652. Int J Cancer. 2005. PMID: 15499612 Free article. Review.

7

High efficacy of combined rituximab and gemcitabine on Epstein-Barr virus-associated human B-cell lymphoma obtained after Hodgkin's xenograft in immunodeficient mice.

Decaudin D, Marszak FB, Couturier J, Mathiot C, Martin A, Némati F, Lantz O, Santo Jd, Arnaud P, Bordier V, Vincent-Salomon A, Poupon MF. Decaudin D, et al. Among authors: nemati f. Anticancer Drugs. 2006 Jul;17(6):685-95. doi: 10.1097/01.cad.0000215061.78189.4e. Anticancer Drugs. 2006. PMID: 16917214

8

Imatinib mesylate reduces rituximab-induced tumor-growth inhibition in vivo on Epstein-Barr virus-associated human B-cell lymphoma.

Némati F, Mathiot C, Grandjean I, Lantz O, Bordier V, Dewulf S, Ekue R, Di Santo JP, Poupon MF, Decaudin D. Némati F, et al. Anticancer Drugs. 2007 Oct;18(9):1029-37. doi: 10.1097/CAD.0b013e3281e444cb. Anticancer Drugs. 2007. PMID: 17704653

9

Preclinical assessment of cisplatin-based therapy versus docetaxel-based therapy on a panel of human non-small-cell lung cancer xenografts.

Némati F, Bras-Gonçalves R, Fontaine JJ, de Pinieux G, De Cremoux P, Chapelier A, Daniel C, Laurent-Puig P, Livartowski A, Judde JG, Bordier V, Poupon MF, Decaudin D. Némati F, et al. Anticancer Drugs. 2009 Nov;20(10):932-40. doi: 10.1097/CAD.0b013e32833009cc. Anticancer Drugs. 2009. PMID: 19741504

10

Clinical relevance of human cancer xenografts as a tool for preclinical assessment: example of in-vivo evaluation of topotecan-based chemotherapy in a panel of human small-cell lung cancer xenografts.

Némati F, Daniel C, Arvelo F, Legrier ME, Froget B, Livartowski A, Assayag F, Bourgeois Y, Poupon MF, Decaudin D. Némati F, et al. Anticancer Drugs. 2010 Jan;21(1):25-32. doi: 10.1097/CAD.0b013e3283300a29. Anticancer Drugs. 2010. PMID: 19823076

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

153 results

Search Page